8-hydroxy-N-methylaporphine
From DrugPedia: A Wikipedia for Drug discovery
| 8-hydroxy-N-methylaporphine
| |
| Systematic (IUPAC) name | |
| N/A | |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C17H17NO |
| Mol. mass | 251.32298 |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
[edit] Description
The biochemical and behavioural findings indicate that 8-hydroxy-N-methyl-aporphine (8-OH aporphine) and its N-n-propyl analogue (8-OH PNA) possess weak dopamine/noradrenaline antagonist- and agonist-like properties, respectively. In addition, both aporphines seemed to only weakly influence serotoninergic transmission.
[edit] General Properties
*Molecular Weight
251.32298
*Molecular Formula
C17H17NO
*IUPAC NAME
N/A
*Canonical Smiles
CN1CCC2=CC=CC3=C2C1CC4=C3C=CC=C4O
*Isomeric Smiles
N/A
*XLogP
3.1
*Topological Polar Surface Area
23.5
